Axonal sprouting and synaptic reorganization within the temporal lobe following neuronal injury have been implicated in the pathogenesis of temporal lobe epilepsy (TLE). The molecular species responsible for these structural changes have yet to be fully defined. The recent characterization of molecules whose normal function within the nervous system is to inhibit neurite outgrowth and synaptogenesis prompts the suggestion that a diminution or loss of such molecules might be of relevance to the pathogenesis of TLE. If so, the possibility of developing a novel therapeutic approach to TLE, distinct from currently available symptomatic therapies, to arrest the pathogenetic processes is also raised.
INTRODUCTION
Approximately 40% of all cases of epilepsy take the form of complex partial seizures (CPS) 1, the majority of which originate within the temporal lobe. Patients with this epileptic syndrome have a less favourable prognosis for seizure control compared to those with generalized seizures, 30% of the former remaining intractable to symptomatic medical therapy 2. Although a larger number of such patients than heretofore may benefit from surgical intervention, the statistics nonetheless suggest that there remains a need for novel therapeutic modalities to control or prevent the development of complex partial seizures of temporal lobe origin.
Epileptic phenomena are characterized by neuronal hyperexcitability and paroxysmal discharge of cortical neurones. Neurophysiological studies in both animal models and man suggest that such excessive and abnormally synchronous firing of neurones results from a concurrent enhancement of excitatory synaptic transmission and a decrease in inhibitory synaptic transmission, the resulting imbalance leading to neuronal hyperexcitability 3. These changes in synaptic transmission are mediated by the neurotransmitters glutamate and ~-aminobutyric acid (GABA), respectively 3.
Despite this understanding of the neurophysiology and neurochemistry of the epileptic temporal lobe, relatively little is currently known about underlying neuroanatomical changes. The commonest neuropathological change, seen in the temporal lobes of around 50% of individuals with complex partial seizures 4, is variously known as Ammon's horn sclerosis (AHS), incisural sclerosis, mesial temporal sclerosis or hippocampal sclerosis.
Macroscopical features include fibrous gliosis, shrinkage and atrophy, whilst microscopically there is a patterned neuronal loss affecting principally the pyramidal cell layers in the hippocampal subfields CA1, CA3, and in the dentate hilus, but sparing the granule cells of the dentate gyrus (or fascia dentata) and some pyramidal cells in hippocampal region CA2 4'5 (hippocampal nomenclature of Lorente de No6). In addition to cell loss, neuronal impregnation studies using the Golgi technique have shown dendritic changes in the epileptic hippocampus 7. DeLorenzo and Glaser observed a dramatic reorganization of both dendritic and axonal projections from pyramidal and other neurones within the hippocampus, suggesting the formation of new neuronal processes and synaptic contacts in addition to neuronal loss in the hippocampus s. Hence, they advanced the hypothesis that reactive neuronal plasticity, occurring in response to neuronal injury and degeneration, might play a role in the development and persistence of the epileptic state s'9.
SPROUTING AND NEURONAL PLASTICITY
In the vertebrate peripheral nervous system, injured axons have the capacity to regenerate by sprouting from intact nodes of Ranvier (nodal sprouting) or from the terminals of injured axons themselves (terminal sprouting). Axonal elongation through remaining Schwann cell tubes permits reconstitution of appropriate synaptic contacts (homotypic sprouting) and full restoration of function. Undamaged axons can also sprout collateral branches in response to partial deafferentation, and these collateral sprouts are able to fill vacated synaptic contacts (heterotypic sprouting) thus reorganizing synaptic, circuitry l°. This neuronal plasticity probably underlies the ability of many sub-mammalian vertebrates to achieve functional regeneration following central nervous system (CNS) injury 11, and may be the physiological correlate of learning and memory.
In contrast to the peripheral nervous system, damaged axons in the mammalian CNS usually fail to regenerate, principally because the mammalian CNS environment is inimical to axonal elongation following injury 11. Collateral sprouting does occur, but axon elongation to re-establish appropriate synaptic targets is often not possible because of the nonpermissive nature of the CNS environment. Aberrant, heterotypic, local synapses may, however, be formed. This synaptic reorganization may account for the limited functional recovery seen after mammalian CNS injury, but it may also have less beneficial consequences, for example the development of spasticity is often ascribed to heterotypic sprouting. Sprouting is thus a ubiquitous feature of neuronal injury, whose functional consequences may be beneficial, neutral or detrimental, depending on the precise situation in which it occurs.
NEURITE GROWTH-INHIBITORY FACTORS
The paucity of regeneration following injury to the mammalian CNS as compared to submammalian vertebrates has been chiefly ascribed to the constitutively non-permissive nature of the mammalian CNS environment for axonal regeneration. It is probable that this non-permissive environment is due, at least in part, to the presence of cell-surface and diffusible molecules which inhibit nerve outgrowth 12'13. A number of nerve growthinhibitory factors (NGIFs) have been described recently," some of which have been partially characterized at the molecular level ( Table 1) . As the description of NGIFs is in its infancy, more candidate NGIFs are likely to be discovered in the future.
Schwab and his colleagues have identified two proteins associated with oligodendrocytes and myelin in mammalian CNS which inhibit neurite outgrowth 14 and cause collapse of has not yet been isolated, nor has its functional activity been defined.
It is probable that a number of classes of neuro-inhibitory molecules exist in vertebrates. A 68-amino acid protein of astrocytic origin which can inhibit neurite outgrowth (GIF) has been characterized from normal human brain 24'25. The possibility that derangement of NGIFs might be involved in the pathogenesis of certain diseases of the nervous system is suggested by the observation that GIF is deficient in Alzheimer's disease brain 24, in which a cortical sprouting response is characteristically seen.
AXONAL SPROUTING AND SYNAPTIC REORGANIZATION IN TLE
Evidence to support the hypothesis that neuronal plasticity underlies the development and persistence of TLE 9 has been forthcoming from both animal models and clinical material.
The granule cells within the dentate gyrus normally project their axons, the mossy fibres, to the giant pyramidal neurones of the adjacent CA3 subfield of the hippocampus e. Lesion studies have shown that following damage to pyramidal cells in CA3, mossy fibres may sprout axon collaterals into the inner molecular layer of the dentate gyrus where the dendrites of granule cells are normally situated 26'27. Such a recurrent pathway could theoretically lead to abnormal excitatory input to dentate granule cells ('feedback excitation'), and hence constitute a plausible anatomical substrate for the development of repetitive electrical discharge, neuronal hyperexcitability and epileptic seizures.
This sprouting response may be demonstrated using various markers for mossy fibres and their axon collaterals. The high zinc content of mossy fibres permits their visualization by Timm-sulphide histochemistry 2s. Mossy fibres are excitatory, and high densities of excitatory amino acid receptors are found in regions to which they project (for example CA3), particularly in their terminal arborization. Kainic acid (KA) binding sites are located presynaptically on mossy fibre terminals, and hence an increased density of high affinity KA binding sites is also a marker of mossy fibre sprouting. Immunohistochemistry for dynorphin A, an opioid peptide contained and released i~y mossy fibres and which can generate epileptiform activity in the CA3 region, may also be used to demonstrate sprouting. These techniques have been used to provide evidence indicative of sprouting within the epileptic, as well as the experimentally lesioned, hippocampus.
ANIMAL MODELS: KAINIC ACID AND KINDLING
The discovery that administration of the potent limbic convulsant kainic acid (KA) to rats produces lesions remarkably similar to human mesial temporal sclerosis has provided a useful model system for the study of TLE 29. After KA-induced lesions, axons of the dentate granule cells (mossy fibres) are observed to sprout collateral fibres which grow across the granule cell layer to form a plexus in the inner molecular layer of the granule cell dendrites 3°. Although this recurrent pathway may seem a plausible and attractive neuroanatomical explanation for seizure activity, the exact relation of structural change to functional consequence remains a critical question. Although evidence has been presented suggesting that these synaptic rearrangements do promote seizure activity 3°'31 the case is not entirely proven. Changes are unlikely to be confined solely to the mossy fibres: other neuronal systems are also likely to sprout, for example GABAergic fibres 32, suggesting that anomalous inhibitory synapses, as well as excitatory synapses may contribute to hyperexcitability. Indeed, Sloviter has advanced evidence suggesting that hyperexcitability precedes dentate synaptic reorganization, and is associated with a selective loss of interneurones which is presumably the stimulus for axon sprouting ~3. According to this interpretation, mossy fibre sprouts innervate the GABAergic basket cells of Cajal, the most important type of interneurone in the hippocampus, so enhancing the inhibition of granule cells, thus producing a primarily inhibitory, and hence beneficial, rather than epileptogenic, effect. The observations of Cronin et al go some way to reconciling the disparate viewpoints: their observations that GABAA receptor antagonists produce synchronous bursts in granule cells only in hippocampal slices which show sprouting suggests that both recurrent inhibitory and excitatory circuits are formed, the latter emerging only when GABA-mediated synaptic inhibition is lost 34.
Similar morphological observations have been made in a further model of TLE, namely the kindled rat 3s. Administration of repeated subconvulsive electrical or chemical stimuli to the hippocampal afferent pathways eventually produces seizures of increasing intensity and a permanent susceptibility to seizures, the kindled state. Such altered functional activity in the hippocampus results in morphological sprouting of mossy fibres into the supragranular zone of the dentate gyrus as evidenced by Timm histochemistry 3e, presumably as a result of altered gene expression (vide infra). Moreover, the initial appearance of mossy fibre synaptic terminals in the supragranular layer occurs four days after the initiation of kindling, a time course compatible with axon A.J. Lamer Table 2 ). Increased Timm staining in the supragranular layer of the dentate gyrus has been reported by several groups in both adult 41-~ and childhood epilepsy 4°. These qualitative results from Timm histochemistry have been complemented by quantitative autoradiographic studies of excitatory amino acid binding sites. An increased density of KA receptors was observed in the CA3 region and the fascia dentata by Represa et a145, whilst Geddes et a146 found an increase in both KA and N-methyl-D-aspartate (NMDA) receptors in the entorhinal cortex (the source of afferent input to the dentate gyrus via the perforant pathway) and the dentate gyrus. The latter observation was confirmed by McDonald et a147. Increased immunoreactivity for dynorphin A has been reported to closely parallel the changes in Timm staining 42'4s.
As with animal models, mossy fibre sprouting is unlikely to be the only change in the human epileptic hippocampus. Immunohistochemical studies have shown loss of the peptides somatostatin and neuropeptide Y, suggesting a loss of inhibitory interneurone connections 4s. Loss of somatostatin producing interneurones with up-regulation of dentate somatostatin receptors has been reported to be a specific and characteristic change in human TLE, since levels of other peptides (CCK octapeptide, VIP, dynorphin Al-17) remain normal 49. Normal immunoreactivities for GABA 4s and for glutamate decarboxylase, the GABA synthetic enzyme 5°, have been reported. Despite this anatomical evidence for preservation of the GABAergic system, this does not necessarily imply functional normality. The changes are similar to those seen in the KA model system where loss of GABAmediated inhibition is thought to occur as a result of synaptic rearrangement of GABAergic neurones34; there is some evidence for similar pathophysiology in human epileptic tissue 51 (vide infra), perhaps secondary to loss of interneurones. Furthermore, GABAA receptors are decreased in certain hippocampal areas 47. As with animal studies, the critical question of the functional significance of these morphological changes in human hippocampus is uncertain. Suggestive circumstantial evidence includes the correlation between surgical removal of'sprouted' hippocampus and reduced seizure activity 41. More direct evidence is forthcoming from the recording of.electrical responses from dentate granule cells in resected temporal lobes following either orthodromic (perforant path) or antidromic (mossy fibre axons and their collaterals) stimulation. Isokawa and Levesque correlated epileptogenic responses of individual dentate granule cells to applications of NMDA with loss of dendritic spines and beading of dendritic shafts 52. These changes may be the functional correlate of the dendritic abnormalities originally observed by Scheibel et al. 7 These hyperexcitable responses of dentate granule cells may also reflect a decrease in GABA-mediated synaptic inhibition 51, since similar responses in the normal rat hippocampus could only be elicited in the presence of the GABAA antagonist bicuculline. The correlation of abnormal antidromic field responses with extent of mossy fibre reorganization (as judged by degree of Timm staining) in a subgroup of TLE patients supports the hypothesis that mossy fibre terminals in the supragranular layers do have functional consequences which may underpin.seizure activity, at least in some patients 44.
Hence, human studies have borne out the animal models which suggest an epileptogenic role for axonal sprouting and synaptic reorganization in the temporal lobe.
MOLECULAR FACTORS INVOLVED IN SPROUTING
The molecular factors which induce and modulate dentate granule cell mossy fibre sprouting in TLE are currently unknown, but some circumstantial experimental evidence has been forthcoming.
The development, survival and maintenance of neuronal cells is dependent on retrogradelytransported neurotrophic factors, present in limiting amounts in target areas. Upregulation of such neurotrophic factors might prompt axonal sprouting. A number of experimental studies have now shown rapid (within hours) and selective, but transient (24-48 hours duration), increases in the expression of genes for the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in dentate granule cells after seizures 53-55, but neurotrophin-3 (NT-3) mRNA levels fall 54'55. The largest alterations are in BDNF mRNA levels, and these elevations are also seen in areas outside the hippocampus 53. mRNAs for the neurotrophin receptors trkB and trkC also rise in dentate granule cells, but trkA is unaltered sS.
Lowenstein and colleagues have documented an increase in neurotrophic activity in saline extracts of homogenized temporal lobe from KA-treated rats using a neuronal survival assay 66. This activity was significantly increased 12 hours at~r kainate treatment, peaked after seven days, but was still evident after two months. Antibody-neutralization assays at seven days suggested that at least part of this activity consisted of NGF, most of the remainder being ciliary neurotrophic factor (CNTF). NGF-like activity has also been detected in fresh human cortical tissue (resected temporal lobe seizure foci), which can be significantly inhibited in a bioassay of sympathetic neurite outgrowth by polyclonal antiserum to NGF 57. The difficulty in obtaining suitable control tissues makes it impossible to adjudge whether this activity is elevated.
Immunoreactivity for molecules related to the neural cell-adhesion molecule (NCAM), which promotes neurite outgrowth, has been found to correlate both spatially and temporally with the pattern of Timm staining in the KA-treated epileptic rat 58. At the electron microscopic level, antibody to NCAM-like activity stains both axonal profiles and astrocytes. Hence NCAM may contribute to the synaptic rearrangement of mossy fibres seen in TLE, as may other adhesion or substrate proteins such as L158. The detection of increased levels of mRNA for the axon growth-associated protein GAP-43 in the granule cells of KAtreated rats is also consistent with sprouting of mossy fibres 59.
The up-regulation of genes expressing the neurotrophins NGF and BDNF after experimental hippocampal neuronal injury is brief, lasting a maximum of 48 hours, and the peak of the neurotrophic activity in hippocampal extracts, ascribed mainly to NGF, occurs seven days after injury. Although such changes might be adequate to initiate a sprouting response in the injured hippocampus, it is not clear whether they would be sufficient to maintain it for a period of months in experimental animals 37 or years in man. extracellular matrix, but also from a diminution in neurite growth-inhibitory factors (NGIFs). The constitutively non-permissive nature of the mature mammalian CNS to axonal growth may suggest that a loss of inhibitory (NGIF) activity is more important for sustained axonal growth and synaptic reorganization than a transient increase in neurotrophin expression. An important precedent for such a suggestion stems from studies of tissue extracts from Alzheimer's diseased (AD) brains: AD brain is characterized pathologically by a sprouting response of partially deafferented neurones throughout the cortical neuropil. Using a neuronal survival assay, Uchida et al initially described an increase in neurotrophic activity in AD brain 6°, but this eventually proved to be a loss of a neurite growth-inhibitory protein of astrocytic origin 24'25. Furthermore, Schwab and Thoenen have presented evidence that adult CNS inhibitory activity cannot be overcome by the stimulatory effects of neurotrophic factors 61. Preliminary experiments using an assay of neuronal growth cone collapse, a standard assay for detection of neurite growth-inhibitory molecules 62, have demonstrated abundant collapsing activity in detergent extracts of homogenized rat hippocampus, but no obvious diminution in specific activity in hippocampi seven days after intraperitoneal kainic acid, although longer time points have yet to be tested (Lamer, A.J., Johnson, A.R., Cook, G.M.W., Rudge, J.S., Keynes, R.J., unpublished observations).
The molecular probes to confirm or refute this speculation are only now becoming available. For example, it will be interesting to learn whether there is increased expression of GAP-43 in human epileptic hippocampus, as in the KA rat model 59, since increased expression of GAP-43 may correlate with loss of myelinassociated NGIFs 63.
A PATHOGENETIC ROLE FOR NGIFs IN TLE?
The ontogeny of neuronal pathfinding may depend on the differential expression of factors which are both attractive to and repulsive for neuronal growth cones 19. This differential expression may be recapitulated in pathological states. Hence, a further, intriguing, possibility is that axonal sprouting in TLE may result not only from increased levels of neurotrophins and adhesion molecules of the cell surface and
A THERAPEUTIC ROLE FOR NGIFs IN TLE?
Just as an increased understanding of the neurophysiology and neurochemistry of epilepsy has led to the rational development of new antiepileptic drugs 64, the new insights into the neuroanatomical basis of epilepsy could also herald the development of a new class of reagents for the treatment of epilepsy.
If aberrant neuronal growth and reorganization of synaptic circuitry is central to the pathogenesis of TLE, then therapy with agents whose normal function is to inhibit nerve growth and synaptogenesis would seem logical, the more so if endogenous NGIF deficiency is one of the key molecular determinants of the pathogenetic cascade. Data have emerged to suggest that the myelin-associated inhibitors characterized by Schwab and his colleagues act in the unlesioned CNS to suppress sprouting and maintain synaptic stability is. Furthermore, administration of antibodies to these inhibitors is followed by an expanded pattern of collateral sprouting into a previously denervated area 63, suggesting that the normal role of these NGIFs may be to restrict postnatal plasticity. Hence, exogenous NGIFs and their analogues might be used to diminish or prevent sprouting and so arrest the pathogenetic process.
Studies on a potential therapeutic role for NGIFs in TLE will be facilitated by the availability of two animal models of the condition, namely kainic acid treated and kindled rats 3s. Since the time course of axon sprouting has been carefully documented in the kindled rat 37, it should be feasible to make correlations between time of administration of NGIF therapy and efficacy in reducing seizures. Intuitively, one might imagine that the greatest benefit of NGIFs will be as prophylactic agents, preventing or diminishing axon sprouting immediately after injury to hippocampal neurons. The documented latent period between a hippocampal neuronal insult and the onset of axonal sprouting may represent a window of therapeutic opportunity for the prophylactic use of NGIFs 37. Alternatively, the possibility that a long-lasting diminution in the level of NGIFs permits axonal sprouting in the hippocampus (vide supra) suggests that exogenous NGIF treatment long after the original injury may also be of therapeutic value.
Could NGIFs have a prophylactic and/or therapeutic role in human TLE? It is well recognized that AHS, the commonest neuropathological correlate of TLE, is significantly associated with a history of febrile convulsions, birth injury, and episodes of status epilepticus 4. These phenomena might be indicators for NGIF therapy, but would also encompass many individuals who might develop AHS but were not destined to subsequently develop TLE. It is recognized that although initial neuronal damage in the hippocampus is linked closely to metabolic and ionic events arising during the greatly enhanced neuronal activity of a seizure, the consequent glial reaction and scarring gradually 'ripen 'es. At some later stage these changes may disrupt normal cerebral activity with the induction of further epileptic attacks. This 'ripening' period may be analogous to the window of therapeutic opportunity in animal models 37, but its exact duration remains to be defined. The observation of dendritic changes in the human epileptic hippocampus also Suggests that TLE might reflect an ongoing pathological process 7 rather than resulting from a single, discrete, cortical insult early in life as was once thought. Such observations further suggest a place for NGIF therapy even many years after the onset of seizures. Gowers recognized, almost a century ago, that epilepsy is a self-perpetuating disease, the abnormal functional activity of each seizure occurring in such a way as to facilitate the subsequent recurrence of the same functional activity 66. Loss of NGIFs may be the physiological correlate of this self-perpetuating activity, and hence exogenous NGIF therapy may represent a mechanism to abrogate this residual effect. Which of the NGIFs described might be used in a therapeutic trial? Currently, this is an academic question since only two NGIFs have been defined at both the protein and genetic level to date, namely human metallothioneinlike GIF 24 and chick collapsin 22. Both of these molecules, and some of the other NGIFs which are as yet only partially characterized, are known to be glycoproteins, for example the posterior half somite-derived protein 2° and the posterior tectal membrane protein 21. Proteins will not cross the intact blood-brain barrier, so obviating the simple approach of intravascular injection or infusion therapy and necessitating a more invasive approach, namely intracerebral or intraventricular injection. Such a requirement would severely limit the clinical acceptability of NGIF treatment. Linkage to a lipid-soluble carrier molecule might circumvent this problem.
The definition of NGIFs at the protein and genetic level 22-25 should be the prelude to the characterization of the cellular receptor(s) for these proteins. This will be an advance of fundamental importance with many implications. It will permit the development of so-called 'small molecule' ligands, analogues of NGIFs, which, unlike proteins, could cross the bloodbrain barrier following intravascular administration. Such reagents would provide not only new therapeutic agents, but also the possibility of functional imaging of axonal sprouting in an injured temporal lobe by conjugation of ligands with positron emitting isotopes; imaging of functional rearrangement after brain injury has already proven possible by this method 6v. Functional imaging should improve the selection of potential candidates for NGIF therapy by identifying those in whom sprouting is actually occurring (pathogenetic heterogeneity in TLE is certainly possible44), and would also indicate the distribution and localization of administered ligands within the CNS.
Kindling, and by extension sprouting, is thought to be relevant to the psychopathology of TLE as well as epileptogenesis ss, and manipulation of various neurotransmitter receptor types by drug therapy has occasionally resulted in unwanted psychotic effects. NGIF therapy, aimed at a neuroanatomical rather than a neurochemical target, should hopefully avoid this pitfall.
CONCLUSION
The study of axonal sprouting and synaptic reorganization in the epileptic hippocampus has given new insights into the pathogenesis of temporal lobe epilepsy. Basic research studies have characterized molecules which normally function within the CNS to inhibit neurite outgrowth and synapse formation. These findings have prompted the suggestion of both a possible pathogenetic role for such molecules in temporal lobe epilepsy, and also the possible development of novel therapeutic approaches utilizing these molecules which aim to diminish or prevent the pathogenetic, epileptogenic changes. Although still a long way from routine clinical application, these studies may eventually enable physicians to tackle the pathological anatomy of epilepsy, which is recognized to reinforce itself with each successive seizure.
